Why DMAC? DiaMedica Therapeutics Inc. Analysis, Price & AI Insights | Whystock
DMAC
$6.05-0.13 (-2.10%)
Market ClosedLast close May 4
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.